Trends in basal insulin prescribing in older adults with chronic kidney disease in Ontario, Canada: A population-based analysis from 2010 to 2020.

Kristin K ClemensAlexandra M OuédraogoMelody LamFlory Tsobo MuandaEmma LoeschnikPiotr WilkSalimah Z Shariff

Published in: Diabetes, obesity & metabolism (2022)

In an era of new oral and injectable diabetes medications, the use of basal insulin has declined in older adults with CKD. However, in those with more advanced CKD, basal insulin, particularly newer analogues, remain a mainstay treatment.

Keyphrases

chronic kidney disease
type diabetes
glycemic control
end stage renal disease
physical activity
cardiovascular disease
primary care
emergency department
insulin resistance
molecular docking
adipose tissue
community dwelling
weight loss
combination therapy
tissue engineering
electronic health record